A Study of Hydroxychloroquine and Zinc in the Prevention of COVID-19 Infection in Military Healthcare Workers (COVID-Milit)

Ajili et al., NCT04377646, COVID-Milit, NCT04377646, Jul 2020

HCQ for COVID-19

1st treatment shown to reduce risk in March 2020, now with p < 0.0000000001 from 426 studies, used in 59 countries.

No treatment is 100% effective.
Protocols combine treatments.

Estimated 660 participant HCQ prophylaxis RCT with results not reported over 6 years after estimated completion.
37 HCQ RCTs have results missing long after expected1-37
The trials report a total of 20,499 patients, with 12 trials having actual enrollment of 3,639, and the remainder estimated.
Study covers HCQ and zinc.
Ajili et al., 31 Jul 2020, Double Blind Randomized Controlled Trial, placebo-controlled, trial NCT04377646 (history) (COVID-Milit). Contact: faida1977@yahoo.fr, nejlastam@gmail.com.